Why is Chemo Pharma Lab falling/rising?

As of 03-Nov, Chemo Pharma Laboratories Ltd is currently priced at 130.00, reflecting a decrease of 0.85, or 0.65%. The stock has shown a mixed performance recently, with a 4.67% increase over the past week, although it has declined by 1.52% over the past month. Notably, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend. Additionally, there has been a significant rise in investor participation, with delivery volume increasing by 277.83% compared to the 5-day average. However, the stock underperformed its sector by 0.75% today, and there is no available information on positive or negative factors impacting its recent movement.
Broader Market Context: In comparison to the benchmark, the Sensex has declined by 0.94% over the past week, while Chemo Pharma's stock has outperformed this benchmark. Year-to-date, Chemo Pharma has gained 18.35%, significantly outpacing the Sensex's 7.47% increase. This suggests that while the stock is experiencing a slight decline today, its overall performance remains strong relative to the broader market trends.